NCT00388011View on ClinicalTrials.gov

Efficacy and Safety of Intranasal Morphine for Pain After Bunion Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Hallux Valgus
Interventions
DRUG

Intranasal Morphine (MNS075) 3.75 mg

Intranasal Morphine (MNS075) 3.75 mg

DRUG

Intravenous Morphine 7.5 mg

Intravenous Morphine 7.5 mg

DRUG

Intranasal morphine (MNS075) 7.5 mg

Intranasal morphine (MNS075) 7.5 mg

DRUG

Intranasal morphine (MNS075) 15 mg

Intranasal morphine (MNS075) 15 mg

DRUG

Intranasal morphine (MNS075) 30 mg

Intranasal morphine (MNS075) 30 mg

DRUG

Intranasal placebo

Intranasal placebo

Sponsors
All Listed Sponsors
lead

Javelin Pharmaceuticals

INDUSTRY